Navigation Links
Drug Safety Center Update: Employee Alleges Actos Maker Valued Sales Over Safety
Date:3/21/2013

Philadelphia, PA (PRWEB) March 21, 2013

The medication safety advocates at DrugRisks.com are announcing updated information on the site for patients who have taken the diabetes drug Actos. In an ongoing trial over Actos bladder cancer side effects*, a former employee recently alleged in testimony that drug maker Takeda put profit concerns over safety.

DrugRisks was created to provide those taking popular prescription drugs with the latest safety alerts, recalls, studies and legal news. Visitors can determine if other patients are experiencing similar side effects and decide if they need legal advice for current litigation.

Health experts with the FDA** and European Medicines Agency*** have warned patients that long-term use of Actos may be linked to increased risks of bladder cancer. The drug has also been banned in France and Germany****.

The maker of Actos, Takeda Pharmaceuticals, now faces Actos lawsuits from as many as 3,000 patients over bladder cancer*****. Over 1,200 of these have been consolidated in a special multi-district federal court in Louisiana, while others are pending in California.

DrugRisks has added information showing the first Actos lawsuit trial in California* began this month for a man dying of bladder cancer*****. Also, a former pharmacologist for Takeda testified that company emails suggested they were more concerned with continued sales of the drug rather than the safety of patients*****.

Although trials have begun, lawyers are still helping those diagnosed with bladder cancer after taking Actos file claims. Anyone affected is urged to contact the DrugRisks Safety Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of drug injury litigation against large pharmaceutical companies, DrugRisks only recommends lawyers and law firms who have already handled Actos lawsuits.
Visit http://www.DrugRisks.com today for more information on Actos bladder cancer research, side effects and litigation news, or to speak with a lawyer.

*Cooper v. Takeda Pharmaceuticals America, Inc., CGC-12-518535, California Superior Court (Los Angeles)
**http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm
***http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/public_health_alerts/2011/07/human_pha_detail_000033.jsp&mid=WC0b01ac058001d126&source=homeMedSearch&category=human
****cbsnews.com/8301-504763_162-20070492-10391704.html
*****bloomberg.com/news/2013-03-05/takeda-put-actos-sales-ahead-of-user-safety-witness-says.html

Read the full story at http://www.prweb.com/releases/actos-lawsuit/actos-lawsuits/prweb10547940.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New ASTRO white paper recommends peer review to increase quality assurance and safety
2. Studies for approval of new drugs have insufficient patients to evaluate safety
3. d'Oliveira & Associates Releases Zimmer Knee Infographic Providing Important Safety Information on High-Flex Knees
4. New Guidelines Raise Safety Bar on Concussions
5. Report: Communications technology among tools needed to aid miner safety
6. The Healthy Facilities Institute (HFI) Forms Educational Partnership with the National Floor Safety Institute (NFSI)
7. ERs Not Doing Enough to Educate Parents on Car-Seat Safety: Study
8. Space Heater Safety Tips Can Help Prevent Burns, Fires
9. Internet searches can identify drug safety issues well ahead of public alerts
10. Emergency departments not doing enough to educate parents about car seat safety
11. Report Details Steps to Boost Patient Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... EDWARDSVILLE, Ill. (PRWEB) , ... ... ... University Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and ... educated healthcare professionals on guideline updates for the primary prevention of cardiovascular ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... LOS ANGELES (PRWEB) , ... October 12, 2017 ... ... of Parsa Mohebi Hair Restoration, has recently contributed a medical article to the ... doctors, on cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/22/2017)... DIEGO , Sept. 22, 2017 AVACEN ... medical device is now successfully helping those with the ... Fibromyalgia diagnosed Amanda in Essex, ... dressed and washing my hair, experiencing no sleep at ... in painful spasm… I cannot recommend [the AVACEN 100] ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
Breaking Medicine Technology: